Literature DB >> 11566341

Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families.

J Lahti-Domenici1, K Rapakko, K Pääkkönen, M Allinen, H Nevanlinna, M Kujala, P Huusko, R Winqvist.   

Abstract

In the Finnish population, identified mutations in BRCA1 and BRCA2 account for a less than expected proportion of hereditary breast and ovarian cancer. All previous studies performed in our country have concentrated on finding germ-line mutations in the coding and splice-site regions of these two genes. Therefore, we wanted to use a different methodological approach and search for large genomic rearrangements, to exclude the possibility of biased BRCA1 and BRCA2 mutation spectra due to known limitations of the previously used PCR-based detection methods. Our results support earlier notions that other genes than BRCA1 and BRCA2 will explain a majority of the still unexplained cases of hereditary susceptibility to breast and ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566341     DOI: 10.1016/s0165-4608(01)00437-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  12 in total

1.  Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

Authors:  Nadine Puget; Sophie Gad; Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Am J Hum Genet       Date:  2002-03-05       Impact factor: 11.025

2.  Screening for genomic rearrangements at BRCA1 locus in Iranian women with breast cancer using multiplex ligation-dependent probe amplification.

Authors:  Vahid R Yassaee; Babak Emamalizadeh; Mir Davood Omrani
Journal:  J Genet       Date:  2013-04       Impact factor: 1.166

3.  A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques.

Authors:  Annika Bergman; Anna Flodin; Yvonne Engwall; Eva L Arkblad; Kerstin Berg; Zakaria Einbeigi; Tommy Martinsson; Jan Wahlström; Per Karlsson; Margareta Nordling
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

Authors:  Maurizia Dalla Palma; Susan M Domchek; Jill Stopfer; Julie Erlichman; Jill D Siegfried; Jessica Tigges-Cardwell; Bernard A Mason; Timothy R Rebbeck; Katherine L Nathanson
Journal:  Cancer Res       Date:  2008-08-14       Impact factor: 12.701

5.  Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.

Authors:  Helena Rudnicka; Tadeusz Debniak; Cezary Cybulski; Tomasz Huzarski; Jacek Gronwald; Jan Lubinski; Bohdan Gorski
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

6.  Genomic rearrangements in BRCA1 and BRCA2: A literature review.

Authors:  Ingrid Petroni Ewald; Patricia Lisboa Izetti Ribeiro; Edenir Inêz Palmero; Silvia Liliana Cossio; Roberto Giugliani; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2009-09-01       Impact factor: 1.771

7.  BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.

Authors:  Ingrid Petroni Ewald; Silvia Liliana Cossio; Edenir Inez Palmero; Manuela Pinheiro; Ivana Lucia de Oliveira Nascimento; Taisa Manuela Bonfim Machado; Kiyoko Abe Sandes; Betânia Toralles; Bernardo Garicochea; Patricia Izetti; Maria Luiza Saraiva Pereira; Hugo Bock; Fernando Regla Vargas; Miguel Ângelo Martins Moreira; Ana Peixoto; Manuel R Teixeira; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2016 Apr-Jun       Impact factor: 1.771

8.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

9.  High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.

Authors:  Petra Vasickova; Eva Machackova; Miroslava Lukesova; Jiri Damborsky; Ondrej Horky; Hana Pavlu; Jitka Kuklova; Veronika Kosinova; Marie Navratilova; Lenka Foretova
Journal:  BMC Med Genet       Date:  2007-06-11       Impact factor: 2.103

10.  Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.

Authors:  Katri Pylkäs; Hannele Erkko; Jenni Nikkilä; Szilvia Sólyom; Robert Winqvist
Journal:  BMC Cancer       Date:  2008-05-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.